Clearance Summary
Comaneci, Comaneci Petit, Comaneci 17 received FDA 510(k) clearance under submission number DEN170064, sponsored by Rapid-Medical , Ltd.. The device was reviewed via the Direct premarket notification pathway and assigned to the Neurology review panel. The statutory decision date of record is 2019-04-24.
- Submission: DEN170064
- Applicant / Sponsor: Rapid-Medical , Ltd.
- Clearance pathway: Direct
- Review panel: Neurology
- Device class: Class II
- Regulation citation: 21 CFR 882.5955
- Decision date: 2019-04-24
Classification & Regulation
This clearance is catalogued under FDA product code PUU and 21 CFR 882.5955, within the Neurology review panel as a Class II device.